Subject: ERN
Flotek Announces First Quarter 2021 Results
HOUSTON, May 10, 2021 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced results for the first three months ended March 31, 2021.
John W. Gibson, Jr., Chairman, President, and Chief Executive Officer stated: "While we experienced a slow start to the quarter due to the continued challenging macro-environment and impacts of Winter Storm Uri, we are pleased with our progress through the quarter as demand significantly increased across both segments towards the end of the quarter and continued into this quarter. We are excited about the momentum we have and are optimistic about our opportunities for growth across our business as the market continues its recovery in the latter half of the year.
"We are accelerating our ESG solutions, which we believe will be a key growth driver as the energy market increases its focus on ESG amid an evolving regulatory framework. Over the years, we have built a leading position as a developer of green chemistry solutions, and we are delivering our suite of greener chemistry and data solutions to meet our customers' evolving needs today. Additionally, we continue to see significant opportunities in international markets and are optimistic about the momentum we are gaining in key growth markets. Lastly, we are strengthening our liquidity to improve our financial flexibility. As a result of these actions, we continue to be confident in our long-term strategy, and I look forward to working with our outstanding leadership team to further improve operational and financial performance."
First Quarter Financial Results
- Consolidated Revenues: Flotek generated first quarter 2021 consolidated revenue of $11.8 million, down 2.8% from $12.1 million in the fourth quarter, and below $19.4 million in the first quarter last year. The year-over-year decrease in revenue was driven by trends in the macro-environment for U.S. onshore drilling and completion activity and the COVID-19 pandemic continues to pressure productivity and global customer demand.
- Consolidated Operating Expenses: Consolidated operating expenses (excluding depreciation and amortization) were $13.8 million in the first quarter 2021, a 39.6% decline from $22.8 million in the same period last year and a 43.3% decline from the prior quarter. The year-over-year decline was driven by a reduction in costs of sales due to lower sales, as well as lower operating expense driven by consolidation of corporate facilities, reduction of equipment rentals, lowered personnel costs and supply chain expenses.
- Corporate General & Administrative Expenses (CG&A): Corporate general and administrative expenses for the first quarter of 2021 were $4.4 million, compared to $4.5 million for the first quarter of 2020 and $3.7 million for the fourth quarter of 2020. The year-over-year decline was primarily driven by lower personnel and severance costs that occurred in the first quarter 2020, as well as a reduction in occupancy costs as the Company moved out of its corporate headquarters and consolidated its Global Research & Innovation Center. The sequential increase was primarily driven by an increase in one-time legal, accounting and other professional fees, offset by a decrease in compensation.
- Adjusted EBITDA: Adjusted EBITDA for the first quarter 2021 was a loss of $6.6 million, slightly below the $6.8 million loss in the fourth quarter of 2020, driven by an increase in one-time professional fees, offset by lower compensation.
- Loss from Operations: The Company reported a loss from operations for the first quarter 2021 of $8.3 million, or a loss of $0.12 per basic/diluted share, compared to a loss from operations in the first quarter 2020 of $64.0 million, or a loss of $1.07 per basic/diluted share which included a non-recurring charge of $57.5 million related to the impairment of property, plant, and equipment, right-of-use assets, and intangible assets.
Balance Sheet and Liquidity
As of March 31, 2021, the Company had cash and equivalents of $33.9 million, with significant year-over-year improvements in cash usage driven by operational efficiencies across the business. Flotek also had a combined $5.7 million of loans outstanding pursuant to the Paycheck Protection Program ("PPP") related to the "Cares Act."
Chemistry Technologies Segment: Energy Chemistries & Professional Chemistries
In the first quarter, sales in the Chemistry Technologies segment declined sequentially 5.0% to $10.3 million. The decrease was primarily a result of continued market volatility in the macro-environment impacting energy supply and major disruption in February from Winter Storm Uri, impacting the entire supply chain. The segment experienced notable pickup in March as demand significantly increased. Highlights from the quarter include:
- Despite the winter storm in February, the Company saw a rebound in its domestic energy chemistries business, up 56%, on a sequential basis. Internationally, following headwinds in market activity and purchasing delays, the Company regained traction towards the end of the quarter.
- The Company engaged with C-Suite leaders at E&Ps to reintroduce the Company's Environmental, Social and Governance-focused (ESG) value proposition to deliver cost-effective, environmentally friendly, safer chemistry solutions.
- In the quarter, the Company initiated key field trial applications for its green, reservoir-centric chemistry technologies.
- The Company hired Nathan Snoke as Vice President of Energy Chemistries. A global leader in differentiated oilfield services, Snoke joins the Company from Halliburton, where he was most recently Senior Region Manager of Europe, Eurasia, and Sub-Sahara Africa, based in London. Nathan brings more than 16 years of oil and gas experience to Flotek, ranging from field operations to senior-level management across multiple continents.
- In the first quarter, Flotek launched its new professional chemistries brand, Flotek Protekoltm, which includes a comprehensive line of surface cleaners, degreasers, wipes, disinfectants and sanitizers made in the USA.
- Flotek formed a strategic agreement with a major global manufacturer of specialty and intermediate chemicals in the first quarter to produce and package EPA-registered disinfectant wipes.
- The Company hired Matthew Sullivan as Vice President of Professional Chemistries to lead business development. Sullivan has more 30 years of janitorial and sanitizing sales and marketing expertise, including Georgia-Pacific, Clorox, Kimberly Clark and Scott Worldwide.
Data Analytics Segment
In the first quarter, Data Analytics' sales improved 16.7% sequentially to $1.5 million, primarily driven by an increase in new equipment sales in North America. Flotek continued to enhance its offerings and increase its efficiency in delivering solutions, while targeting new customers and markets to transform their businesses through real-time data and analytics. Highlights include:
- Added new customers and increased repeat purchases from existing customers, demonstrating the value JP3 delivers to its customers with the multi-applications of its technologies.
- Made progress on its international market entry strategy by continuing meaningful engagement with potential customers in the Middle East, Africa and Asia. During the first quarter, Flotek secured its second pilot in the Middle East and completed its site survey with its first international pilot.
- Implemented software development enhancements by accelerating Artificial Intelligence ("AI") and machine learning capabilities, improving the precision of measurement between batches of refined hydrocarbon products ? reducing time, waste and money spent. During the first quarter, the company launched its first application using AI in batch interface for pipelines and successfully installed the application in two locations.
- Accelerated discussions with customers on its "green benefits" portfolio of applications which helps companies reduce their carbon footprint, energy consumption and emissions. The Company will continue to help customers improve their ESG performance through its JP3 product offerings.
Termination of Agreement with Florida Chemical Company
As previously disclosed in an 8-K filing on March 29, 2021, Flotek Chemistry, LLC, a wholly-owned subsidiary of Flotek, delivered a notice of termination for the Supply Agreement between Flotek and Florida Chemical Company, LLC (FCC) dated February 28, 2019 following Florida Chemical's refusal to allow Flotek to exercise its contractual rights to audit the books and records related to the cost of terpene purchased. Flotek believes it has sufficient terpene inventory and alternative terpene supply sources to meet its requirements and does not intend to purchase additional supplies of terpene from FCC.
Going forward, the Company's supply management strategy will align terpene purchases with its demand and does not expect that the termination of the Supply Agreement will have a material effect on its operations or ability to meet customer needs.
Conference Call Details
Flotek will host a conference call on Tuesday, May 11, 2021, at 9:00 am CDT (10:00 a.m. EDT) to discuss its first quarter results ended March 31, 2021. To participate in the call, participants should dial 844-835-9986 approximately five minutes prior to the start of the call. The call can also be accessed from Flotek's website at www.flotekind.com.
About Flotek Industries, Inc.
Flotek Industries, Inc. is a technology-driven, specialty chemistry and data company that helps customers across industrial, commercial and consumer markets improve their Environmental, Social and Governance performance. Flotek's Chemistry Technologies segment develops, manufactures, packages, distributes, delivers, and markets high-quality cleaning, disinfecting and sanitizing products for commercial, governmental and personal consumer use. Additionally, Flotek empowers the energy industry to maximize the value of their hydrocarbon streams and improve return on invested capital through its real-time data platforms and green chemistry technologies. Flotek serves downstream, midstream and upstream customers, both domestic and international. Flotek is a publicly traded company headquartered in Houston, Texas, and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit Flotek's web site at www.flotekind.com.
Forward-Looking Statements
Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.
Flotek Industries, Inc. | |||
Unaudited Condensed Consolidated Balance Sheets | |||
(in thousands, except share data) | |||
March 31, 2021 | December 31, 2020 | ||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | $ 33,945 | $ 38,660 | |
Restricted cash | 40 | 664 | |
Accounts receivable, net of allowance for doubtful accounts of $1,320 and $1,316 at March 31, 2021 and December 31, 2020, respectively | 11,522 | 11,764 | |
Inventories, net | 11,616 | 11,837 | |
Income taxes receivable | 53 | 403 | |
Other current assets | 2,179 | 3,127 | |
Assets held for sale | 546 | ? | |
Total current assets | 59,901 | 66,455 | |
Property and equipment, net | 8,258 | 9,087 | |
Operating lease right-of-use assets | 2,217 | 2,320 | |
Goodwill | 8,092 | 8,092 | |
Deferred tax assets, net | 220 | 223 | |
Other long-term assets | 29 | 33 | |
TOTAL ASSETS | $ 78,717 | $ 86,210 | |
LIABILITIES AND STOCKHOLDERS' & EQUITY | |||
Current liabilities: | |||
Accounts payable | $ 6,483 | $ 5,787 | |
Accrued liabilities | 17,931 | 18,275 | |
Income taxes payable | 20 | 21 | |
Interest payable | 46 | 34 | |
Current portion of operating lease liabilities | 597 | 636 | |
Current portion of finance lease liabilities | 61 | 60 | |
Current portion of long-term debt | 5,023 | 4,048 | |
Total current liabilities | 30,161 | 28,861 | |
Deferred revenue, long-term | 104 | 117 | |
Long-term operating lease liabilities | 8,099 | 8,348 | |
Long-term finance lease liabilities | 80 | 96 | |
Long-term debt | 642 | 1,617 | |
TOTAL LIABILITIES | 39,086 | 39,039 | |
Stockholders' Equity: | |||
Common stock, $0.0001 par value, 140,000,000 shares authorized; 78,275,814 shares issued and 72,702,298 shares outstanding at March 31, 2021; 78,669,414 shares issued and 73,088,494 shares outstanding at December 31, 2020 | 8 | 8 | |
Additional paid-in capital | 360,537 | 359,721 | |
Accumulated other comprehensive income (loss) | 30 | (19) | |
Accumulated deficit | (286,988) | (278,688) | |
Treasury stock, at cost; 5,573,516 and 5,580,920 shares at March 31, 2021 and December 31, 2020, respectively | (33,956) | (33,851) | |
Total stockholders' equity | 39,631 | 47,171 | |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 78,717 | $ 86,210 | |
Flotek Industries, Inc. | ||||||
Unaudited Condensed Consolidated Statements of Operations | ||||||
(in thousands, except per share data) | ||||||
Three Months Ended | ||||||
3/31/2021 | 3/31/2020 | 12/31/2020 | ||||
Revenue | $ 11,770 | $ 19,416 | $ 12,106 | |||
Costs and expenses: | ||||||
Operating expenses (excluding depreciation and amortization) | 13,801 | 22,841 | 24,327 | |||
Corporate general and administrative | 4,361 | 4,493 | 3,744 | |||
Depreciation and amortization | 307 | 2,191 | 235 | |||
Research and development | 1,542 | 2,555 | 1,540 | |||
Loss (gain) on disposal of long-lived assets | 2 | (33) | (2) | |||
Impairment of fixed, long-lived and intangible assets | - | 57,454 | - | |||
Total costs and expenses | 20,013 | 89,501 | 29,844 | |||
Loss from operations | (8,243) | (70,085) | (17,738) | |||
Other (expense) income: | ||||||
Interest expense | (18) | (4) | (20) | |||
Other (expense) income, net | (33) | (47) | 179 | |||
Total other (expense) income, net | (51) | (51) | 159 | |||
Loss before income taxes | (8,294) | (70,136) | (17,579) | |||
Income tax (expense) benefit | (6) | 6,169 | (102) | |||
Net loss | (8,300) | (63,967) | (17,681) | |||
Loss per common share: | ||||||
Basic | $ (0.12) | $ (1.07) | $ (0.26) | |||
Diluted | $ (0.12) | $ (1.07) | $ (0.26) | |||
Weighted average common shares: | ||||||
Weighted average common shares used in computing basic and diluted loss per common share | 68,447 | 59,836 | 67,586 | |||
Flotek Industries, Inc. | |||
Unaudited Condensed Consolidated Statements of Cash Flows | |||
(in thousands) | |||
Three months ended March 31, | |||
2021 | 2020 | ||
Cash flows from operating activities: | |||
Net loss | $ (8,300) | $ (63,967) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||
Change in fair value of contingent consideration | (335) | - | |
Depreciation and amortization | 307 | 2,191 | |
Provision for doubtful accounts | - | 597 | |
Provision for excess and obsolete inventory | 307 | 529 | |
Impairment of right-of-use assets | - | 7,434 | |
Impairment of fixed assets | - | 30,178 | |
Impairment of intangible assets | - | 19,842 | |
Loss (gain) on sale of assets | 2 | (33) | |
Non-cash lease expense | 105 | 184 | |
Stock compensation expense | 778 | 462 | |
Deferred income tax provision (benefit) | 2 | (133) | |
Changes in current assets and liabilities: | |||
Accounts receivable, net | 255 | 1,675 | |
Inventories, net | (78) | 4,793 | |
Income taxes receivable | 267 | (6,212) | |
Other current assets | 405 | 3,645 | |
Other long-term assets | 541 | - | |
Accounts payable | 695 | (7,666) | |
Accrued liabilities | (317) | (17,522) | |
Income taxes payable | 89 | 226 | |
Interest payable | 12 | - | |
Net cash used in operating activities | (5,265) | (23,777) | |
Cash flows from investing activities: | |||
Capital expenditures | (19) | (42) | |
Proceeds from sale of business | - | 3,281 | |
Proceeds from sale of assets | 2 | 34 | |
Abandonment of patents and other intangible assets | - | 49 | |
Net cash (used in) provided by investing activities | (17) | 3,322 | |
Cash flows from financing activities: | |||
Purchase of treasury stock | (105) | (45) | |
Proceeds from sale of common stock | 38 | 349 | |
Payments for finance leases | (14) | (51) | |
Net cash (used in) provided by financing activities | (81) | 253 | |
Effect of changes in exchange rates on cash and cash equivalents | 23 | (109) | |
Net change in cash, cash equivalents and restricted cash | (5,340) | (20,311) | |
Cash and cash equivalents at beginning of period | 38,660 | 100,575 | |
Restricted cash at beginning of period | 664 | 663 | |
Cash and cash equivalents and restricted cash at beginning of period | 39,324 | 101,238 | |
Cash and cash equivalents at end of period | 33,945 | 80,263 | |
Restricted cash at the end of period | 40 | 664 | |
Cash, cash equivalents and restricted cash at end of period | $ 33,985 | $ 80,927 | |
Flotek Industries, Inc. | ||||||||
Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings | ||||||||
(in thousands) | ||||||||
GAAP Loss from Operations and Reconciliation to Adjusted EBITDA (Non-GAAP) | ||||||||
Three Months Ended | ||||||||
3/31/2021 | 3/31/2020 | 12/31/2020 | ||||||
Loss from Operations (GAAP) | $ (8,300) | $ (63,967) | $ (17,681) | |||||
Interest Expense | 18 | 4 | 20 | |||||
Interest Income | (5) | (269) | (10) | |||||
Income Tax Benefit (Expense) | 6 | (6,169) | 102 | |||||
Depreciation and Amortization | 307 | 2,191 | 235 | |||||
Impairment of Fixed and Long Lived Assets | - | 57,454 | - | |||||
EBITDA (Non-GAAP) | $ (7,974) | $ (10,756) | $ (17,334) | |||||
Stock Compensation Expense | 738 | 462 | 833 | |||||
Severance and Retirement | 33 | 1,538 | 334 | |||||
Inventory Write-Down | - | 2,293 | 9,436 | |||||
M&A Transaction Costs | (157) | - | (366) | |||||
Inventory Step-Up | 48 | - | 108 | |||||
(Gain) loss on Disposal of Assets | 2 | (33) | (2) | |||||
COVID-19 Related Costs | - | - | 202 | |||||
Discontinued Legal Fees | 518 | 249 | 2 | |||||
Winter Storm (Natural Disaster) | 199 | - | - | |||||
Adjusted EBITDA (Non-GAAP) | $ (6,593) | $ (6,247) | $ (6,787) | |||||
(1) Management believes that adjusted EBITDA for the three months ended March 31, 2021 and March 31, 2020, and the three months ended December 31, 2020, is useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the expenses noted above to be outside of the Company's normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish operational goals. |
SOURCE Flotek Industries, Inc.
These press releases may also interest you
|
News published on and distributed by:
